Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers.
Jeffrey Patterson-FortinArindam BoseWei-Chih TsaiCarter GrochalaHuy NguyenJia ZhouKalindi ParmarJean-Bernard LazaroJoyce F LiuKelsey McQueenGeoffrey I ShapiroDavid E KozonoAlan D' AndreaPublished in: Cancer research (2022)
Combined inhibition of NHEJ and MMEJ using two nontoxic, targeted DNA repair inhibitors can effectively induce toxic DNA damage to treat TP53-deficient cancers.